Oling, Reysel Vienne -.
HRN: 17-52-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
CEFUROXIME 750MG (VIAL)
04/08/2024
04/15/2024
IV
210 MG
8 HRS
OR USE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes